Sucampo Receives $15 Million Milestone Payment from Abbott on First Sale of AMITIZA® (lubiprostone) in Japan
[Business Wire] – BETHESDA, Md. & TOKYO–(BUSINESSWIRE)– Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (SPI) today announced that its subsidiary, Sucampo AG, has received a $15 million milestone payment from Abbott’s (NYSE: … more
View todays social media effects on SCMP
View the latest stocks trending across Twitter. Click to view dashboard